Regulation of the insulin-like growth factor-I receptor gene by oncogenes and antioncogenes: implications in human

H Werner1, M Shalita-Chesner, S Abramovitch

  • 1Department of Clinical Biochemistry, Tel Aviv University, Tel Aviv, 69978, Israel. hwerner@post.tau.ac.il

Insights

Tumor suppressors like WT1 and p53 inhibit insulin-like growth factor-I receptor (IGF-I-R) gene activity, while oncogenes stimulate it. This balance regulates cell proliferation and transformation.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • The insulin-like growth factor-I receptor (IGF-I-R) is crucial for cell growth and cancer development.
  • Tumor suppressor genes (e.g., WT1, p53, BRCA1) and oncogenes influence IGF-I-R gene expression.
  • Dysregulation of IGF-I-R signaling is implicated in various cancers.

Purpose of the Study:

  • To investigate the regulatory mechanisms controlling IGF-I receptor gene transcription.
  • To elucidate the roles of specific tumor suppressors and oncogenes in modulating IGF-I-R promoter activity.
  • To understand how the interplay between transcription factors impacts cellular proliferation.

Main Methods:

  • Analysis of IGF-I receptor gene promoter activity.
  • Investigation of transcription factor binding and function.
  • Assessment of cell-surface IGF binding levels.

Main Results:

  • Wild-type tumor suppressors (WT1, p53, BRCA1) suppress IGF-I-R promoter activity.
  • Oncogenes (mutant p53, c-myb) and EWS-WT1 fusion protein stimulate IGF-I-R promoter activity.
  • Differential regulation by transcription factors affects IGF-I-R expression and cell proliferation.

Conclusions:

  • The expression of the IGF-I receptor is tightly controlled by a balance of stimulatory and inhibitory transcription factors.
  • Understanding these regulatory interactions is key to comprehending cell proliferation and transformation processes.
  • Targeting IGF-I-R signaling pathways holds potential for cancer therapy.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...